News by subject: HEALTH

Titan Medical Inc. , a medical technology company focused on single access robotic-assisted surgery (RAS), today announced its attendance at the American Association of Gynecologic Laparoscopy (AAGL) 51st Global Congress on minimally invasive...

The pandemic is placing unprecedented demands on Canada's health care systems and a new report from the Canadian Institute for Health Information (CIHI) examines the impacts on the supply and distribution of health care workers across the country,...

Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, announced the 100th implant in China, signifying the opportunity for its innovative Optimizer® system delivering CCM® therapy in markets...

CALGARY ? The Taylor Family Neonatal Intensive Care Unit (NICU). That will be the name of the new state-of-the-art, two-story NICU at Foothills Medical Centre that will care for the most critical newborns and their families thanks to their $10M...

Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals today announced that it has entered into a collaboration agreement with one of...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has commenced screening subjects for its Phase 1 clinical study of an intravenous formulation...

ARCpoint Inc. (the "Company" or "ARCpoint") a leading US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing services announced today that it expects to release financial results for the third quarter of...

Twenty-two community projects across Ontario are getting a boost thanks to funding from RTOERO's annual community grants campaign.  Since 1968, RTOERO has been a voice for teachers, school and board administrators, educational support staff and...

Organovo Holdings, Inc. , a three-dimensional biology (3D biology) company focused on delivering scientific and medical breakthroughs using novel technologies including 3D bioprinting, today announced that it has successfully advanced the use of its...

Dr. Pierre Debs, Ph.D. announced today the launch of Chain Pharmaceuticals GmbH, a phytocannabinoid drug discovery company leveraging machine learning and real world medical data in the development of clinically proven plant-based medicines for...

Field Trip Health & Wellness Ltd. ("Field Trip" or the "Company"), a global leader in the delivery of psychedelic therapies, today launched Freedom by Field Triptm (the "Program"), a first-of-its-kind one-year hybrid ketamine therapy program that...

Triple Hair Group Inc. ("Triple Hair" or the "Company"), a company specializing in the development of...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization...

Achieve Life Sciences, Inc. , a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced third quarter 2022 financial results...

Canada's leadership in obesity care and related research is on display in Latin America today, as several healthcare associations in Chile release adult obesity treatment guidelines (CPGs) built upon CPGs published in 2020 by Obesity Canada and the...

Aptose Biosciences Inc. ("Aptose") , a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today announced dosing of the first patient to receive a continuous dosing regimen of the G3...

Completed RE104 Phase 1 prespecified dose cohorts and on track to deliver interim Phase 1 analysis in the first calendar quarter of 2023.Appointed Greg Mayes as President and Chief Executive Officer, with Joseph del Moral moving into the role of...

Mindset Pharma Inc. ("Mindset" or the "Company"), a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs,...

Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions for precision medicine, announced today their participation in the upcoming 64th American Society of Hematology (ASH)...

InMed Pharmaceuticals Inc. ("InMed" or the "Company") , a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the first quarter of fiscal year 2023,...

Truepill, the company transforming consumer healthcare by powering first-in-kind B2B digital pharmacy experiences, recently closed a fundraising round that will position the company to invest in serving the needs of its existing customers, driving to...

Small Pharma Inc. (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announce its participation in the following upcoming conferences in...

Revera's Chief Elder Officer, Hazel McCallion received her influenza vaccine on Tuesday, along with 50 employees at Revera's Support Office in Mississauga. Dr. Rhonda Collins, Revera's Chief Medical Officer, was on hand to administer her flu shot,...

A bundle of Alberta high schools and a state-of-the-art national archival facility are among the seven winners of the 2022 National Awards for Innovation and Excellence in Public-Private Partnerships. Presented by The Canadian Council for...

Despite spending more on health care than most other developed countries with universal coverage, Canada has some of the lowest numbers of doctors, hospital beds, and medical technologies?and the longest wait times, finds a new study released today...

Dr. Vince Clinical Research (DVCR), a world-class early phase contract research organization (CRO) specializing in the conduct of Phase I clinical trials, today announced that it has administered the first dose in Ensysce Bioscience's oral Human...

? BPT567, a first-in-class PD1-IL18 immunocytokine, delivers coordinated PD-1 blockade and potent IL-18 signaling to PD-1+ T effector cells resulting in striking antitumor activity ? ? BPT331, a PD1-IL2 cis-signaling immunocytokine with potent...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome's Chief Executive Officer, will...

Baxter International Inc. , a global innovator in kidney care, advanced scientific exchange with 14 new data...

In response to the shortage of molybdenum-99 (Mo-99) that the nuclear medicine community faces in November 2022, the world's major processing facilities and reactors confirm the details of their plans to continue serve the 40 million patients a year...

After the success of the BforKai organization throughout the Atlantic provinces, the Matthews family has once again taken the tragic loss of 19-year-old Kai Matthews to inspire their second campaign, menBaware. The national campaign targets young...

ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that its proprietary ECT-001 Cell Therapy has been administered to 100 patients. ECT-001 Cell Therapy is an investigational UM171-expanded...

Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that William Collier, Arbutus' President and...

Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the addition of Oregon Health & Science University ("OHSU") to its Therapeutic Experience Program (TEP). This...

Ekosi Health, a Canadian-based and Indigenous-owned healthcare provider specializing in clinical cannabinoid therapy, announces its partnership with Cerebra, a leading sleep technology company, as the partners run an Observational Study that will...

Ceapro Inc. ? ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients and disruptive technologies for healthcare and cosmetic industries, announced today...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the presentation of a peer-reviewed abstract to...

Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions, announces the launch of the first commercially available product that can quantify protein glycosylation at single cell...

Aptose Biosciences Inc. ("Aptose") , a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today announced that clinical data for tuspetinib (formerly HM43239), a myeloid kinome...

Irwin Naturals Inc.  (FRA: 97X) ("Irwin" or the "Company") entered into a binding agreement on October 30, 2022, to acquire the assets of Clare Clinic, Inc., d/b/a Florida Mind Health Center, which operates three healthcare clinics in Florida. The...

Kane Biotech Inc. (the "Company" or "Kane Biotech") announces that it has recently submitted a 510(k) premarket notification, which has been received by The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration...

Helius Medical Technologies will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American Congress of Rehabilitation Medicine (ACRM) Conference, held November 8-11 in Chicago. Visitors to booth 512 will see...

Earlier this year the Medical Innovation Xchange (MIX) announced an innovative partnership with the Ontario Ministry of Labour, Immigration, Training and Skills Development called the MIX Knowledge Xchange (MIX-KX). The goal of the MIX-KX is to...

PharmAla Biotech is pleased to announce that it has submitted its pre-IND data meeting package to the US Food and Drug Administration (USFDA) in advance of its pre-IND meeting scheduled for later this month. PharmAla will be requesting FDA feedback...

HBsAg and HBV DNA remain at low levels with no evidence of clinical relapse up to 44 weeks after discontinuing AB-729 and NA therapy Preclinical data suggest that AB-101, an oral PD-L1 inhibitor, in combination with an RNAi, may provide enhanced HBV...

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced it will report its third quarter 2022 financial and operating results after the close of U.S. financial markets on Tuesday, November 8, 2022. Conference...

Arthritis Society Canada is investing in entrepreneurs to help them change the lives of people living with arthritis. For the second year in a row, Canada's leading arthritis charity is challenging entrepreneurs to invent and tailor practical...

Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Company will be presenting three...

Global leaders in the plant-based food and ingredient sector are gathering at The Westin Harbour Castle in Toronto, Ontario for Plant Forward, on November 1 & 2 to shape the future of plant-based food. The event, designed to highlight Canada's...

Rakovina Therapeutics Inc. ("the Company"), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, is pleased to announce the presentation of new data during the 34th...